Corcept Therapeutics Announces Third Quarter Results and Corporate and Development Update

[at noodls] – MENLO PARK, Calif. – October 31, 2012 Corcept Therapeutics Incorporated (CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe … more

View todays social media effects on CORT

View the latest stocks trending across Twitter. Click to view dashboard